Test Price
450 AED✅ Home Collection Available
Immunohistochemistry Single Marker with Interpretation in UAE | 450 AED | DHA Certified
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval with ISO-Certified Transport Chain — archival tissue blocks or slides are collected directly from the referring facility.
- Clinical Guidance: Telephonic Post-Test Result Interpretation by a Certified Pathologist.
- Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
- Price: 450 AED inclusive of retrieval, analysis, and interpretation.
Test Overview & Methodology
Immunohistochemistry (IHC) single marker analysis with expert interpretation precisely detects one specific protein in tumor tissue, enabling accurate cancer subtyping, therapy selection, and prognosis determination. This assay provides a precise immunohistochemical evaluation of a single biomarker based on specialist pathologist interpretation, using validated monoclonal antibodies and digital scoring algorithms.
| Feature | Our DHA-Certified IHC Interpretation | General Histopathology (without interpretation) |
|---|---|---|
| Precision | Monoclonal antibody-based digital scoring with pathologist correlation and quantitative reporting | Descriptive report only; no quantitative marker analysis or scoring |
| Methodology | Standardized IHC on FFPE tissue using internationally validated protocols and automated staining platforms | H&E stain alone without specialized immunostaining |
| Turnaround & Clinical Use | 10 calendar days; includes treatment-relevant biomarker interpretation and clinical correlation | Variable turnaround; lacks integrated clinical guidance for targeted therapy decisions |
Physician Insight & Safety Protocols
“As a diagnostic radiologist, I frequently collaborate with oncologists and pathologists to ensure that immunohistochemistry results are interpreted within the full clinical and imaging context. This single-marker IHC analysis, when correlated with your radiological findings and complete medical history, provides a critical data point for personalised cancer management. Remember that biomarker results complement, never replace, a thorough multidisciplinary evaluation.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA Registration ID: 61713011)
Medication Advisory
Do not discontinue or alter any prescribed medication, including hormone therapy or targeted agents, without consulting your treating physician. Immunohistochemistry results are intended to inform and refine your management plan, not to replace ongoing treatment decisions made by your healthcare team.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Tissue not fixed in 10% formal-saline or not submitted as an FFPE block; insufficient tumor cell content for reliable scoring; biopsy specimen without accompanying histopathology report or clinical history; minors tested without legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: If you develop uncontrolled bleeding, severe pain at the biopsy site, sudden neurological symptoms, chest pain, or shortness of breath, seek immediate emergency medical care — do not wait for IHC results or delay urgent intervention.
Patient FAQ & Clinical Guidance
1. What does an immunohistochemistry single marker with interpretation test detect?
This assay precisely identifies a specific protein marker expressed within tumor tissue, enabling oncologists to classify cancer subtype, predict prognosis, and tailor targeted therapy. The interpretive report includes staining intensity, percentage of positive cells, subcellular localisation, and a diagnostic conclusion aligned with international guidelines. It is essential for planning hormone therapy, immunotherapy, or molecularly driven treatment regimens.
2. Do insurance companies cover this test in the UAE?
Yes, our laboratory works with most major insurance companies in the UAE. You can verify your coverage via WhatsApp at +971 54 548 8731. We send the invoice directly to your insurer after pre-approval. Please send a copy of your insurance card and policy details via WhatsApp to confirm coverage and any applicable co-payment requirements.
3. How is the archival tissue specimen collected and transported?
No patient preparation is required. Our secure medical courier retrieves the formalin-fixed paraffin-embedded (FFPE) tissue block or unstained slides directly from the hospital or pathology laboratory where your biopsy is stored. You must provide a copy of the original histopathology report, biopsy site details, and a brief clinical history. The specimen is transported at controlled ambient temperature in a validated biohazard container, ensuring full viability for IHC staining and analysis.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Rights
- All patient health information is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring lawful collection, storage, and sharing of your medical data.
- Our laboratory systems adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, governing the secure handling of electronic health records and digital diagnostic data.
- Access to your IHC report and personal details is restricted to authorised medical personnel only. You have the right to request access, correction, or deletion of your data as provided under UAE law.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry Single Marker with Interpretation |
| Price (AED) | 450 AED (inclusive of retrieval, analysis, and interpretation) |
| Turnaround Time | 10 calendar days from sample receipt |
| Sample Type / Matrix | Archival Tissue Specimen — Formalin-Fixed Paraffin-Embedded (FFPE) Block or Unstained Slides |
| Methodology Used | Immunohistochemistry (IHC) with monoclonal antibody-based digital scoring and board-certified pathologist interpretation |
| ICD-10-CM Code | C50.911 — Malignant neoplasm of unspecified site of unspecified female breast |
| LOINC Code | 21908-9 — Immunohistochemistry stain, Tissue |
| DHA Facility License & Laboratory Address Invariants | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians